MX390615B - Metodos mejorados para la acilacion del maitansinol. - Google Patents
Metodos mejorados para la acilacion del maitansinol.Info
- Publication number
- MX390615B MX390615B MX2019008652A MX2019008652A MX390615B MX 390615 B MX390615 B MX 390615B MX 2019008652 A MX2019008652 A MX 2019008652A MX 2019008652 A MX2019008652 A MX 2019008652A MX 390615 B MX390615 B MX 390615B
- Authority
- MX
- Mexico
- Prior art keywords
- maytansinol
- amino acid
- acylation
- improved methods
- carboxyanhydride
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
- H01R12/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
- H01R12/50—Fixed connections
- H01R12/51—Fixed connections for rigid printed circuits or like structures
- H01R12/55—Fixed connections for rigid printed circuits or like structures characterised by the terminals
- H01R12/58—Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
- H01R12/585—Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/02—Details
- H05K1/0201—Thermal arrangements, e.g. for cooling, heating or preventing overheating
- H05K1/0203—Cooling of mounted components
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/02—Details
- H05K1/11—Printed elements for providing electric connections to or between printed circuits
- H05K1/115—Via connections; Lands around holes or via connections
- H05K1/116—Lands, clearance holes or other lay-out details concerning the surrounding of a via
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/18—Printed circuits structurally associated with non-printed electric components
- H05K1/181—Printed circuits structurally associated with non-printed electric components associated with surface mounted components
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyamides (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261705731P | 2012-09-26 | 2012-09-26 | |
| PCT/US2013/061839 WO2014052537A1 (en) | 2012-09-26 | 2013-09-26 | Improved methods for the acylation of maytansinol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019008652A MX2019008652A (es) | 2019-09-13 |
| MX390615B true MX390615B (es) | 2025-03-20 |
Family
ID=49328648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015003745A MX366701B (es) | 2012-09-26 | 2013-09-26 | Métodos mejorados para la acilación del maitansinol. |
| MX2019008652A MX390615B (es) | 2012-09-26 | 2013-09-26 | Metodos mejorados para la acilacion del maitansinol. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015003745A MX366701B (es) | 2012-09-26 | 2013-09-26 | Métodos mejorados para la acilación del maitansinol. |
Country Status (27)
| Country | Link |
|---|---|
| US (9) | US9012629B2 (OSRAM) |
| EP (3) | EP3904358A1 (OSRAM) |
| JP (7) | JP6517693B2 (OSRAM) |
| CN (2) | CN104768955B (OSRAM) |
| AU (4) | AU2013323572B2 (OSRAM) |
| BR (2) | BR112015006505B1 (OSRAM) |
| CA (2) | CA3133906C (OSRAM) |
| CY (2) | CY1121415T1 (OSRAM) |
| DK (2) | DK2900676T3 (OSRAM) |
| ES (2) | ES2880754T3 (OSRAM) |
| HR (2) | HRP20190473T1 (OSRAM) |
| HU (2) | HUE055443T2 (OSRAM) |
| IL (2) | IL237899A (OSRAM) |
| LT (2) | LT3486248T (OSRAM) |
| MX (2) | MX366701B (OSRAM) |
| MY (1) | MY169250A (OSRAM) |
| NZ (2) | NZ739573A (OSRAM) |
| PL (2) | PL2900676T3 (OSRAM) |
| PT (2) | PT3486248T (OSRAM) |
| RS (2) | RS58493B1 (OSRAM) |
| RU (2) | RU2648992C2 (OSRAM) |
| SG (1) | SG11201501918UA (OSRAM) |
| SI (2) | SI3486248T1 (OSRAM) |
| SM (2) | SMT201900170T1 (OSRAM) |
| TR (1) | TR201903625T4 (OSRAM) |
| WO (1) | WO2014052537A1 (OSRAM) |
| ZA (1) | ZA201501898B (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY169250A (en) | 2012-09-26 | 2019-03-19 | Immunogen Inc | Improved methods for the acylation of maytansinol |
| CN105585579A (zh) * | 2014-10-24 | 2016-05-18 | 南京联宁生物制药有限公司 | 一种化合物及其制备方法以及美登素dm1的制备方法 |
| KR20170129769A (ko) * | 2015-03-17 | 2017-11-27 | 리제너론 파아마슈티컬스, 인크. | 아미노산 아실화 시약 및 이의 사용 방법 |
| WO2018112334A1 (en) | 2016-12-16 | 2018-06-21 | Bluefin Biomedicine, Inc. | Anti-cub domain-containing protein 1 (cdcp1) antibodies, antibody drug conjugates, and methods of use thereof |
| WO2020212256A1 (en) * | 2019-04-18 | 2020-10-22 | Indena S.P.A. | Diasteroselective process for the preparation of thiol- or disulfide-containing maytansinoid esters and intermediates thereof |
| WO2021107133A1 (ja) | 2019-11-29 | 2021-06-03 | 日本マイクロバイオファーマ株式会社 | メイタンシノールの酵素的生産方法 |
| TW202506651A (zh) | 2023-04-28 | 2025-02-16 | 日商中外製藥股份有限公司 | 使用n-羧基胺基酸酐之含有醯胺基化合物的製造方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6034556B2 (ja) * | 1977-03-31 | 1985-08-09 | 武田薬品工業株式会社 | 抗生物質ｃ−１５００３ |
| US4151042A (en) | 1977-03-31 | 1979-04-24 | Takeda Chemical Industries, Ltd. | Method for producing maytansinol and its derivatives |
| US4137230A (en) | 1977-11-14 | 1979-01-30 | Takeda Chemical Industries, Ltd. | Method for the production of maytansinoids |
| US4265814A (en) | 1978-03-24 | 1981-05-05 | Takeda Chemical Industries | Matansinol 3-n-hexadecanoate |
| JPS5562090A (en) | 1978-10-27 | 1980-05-10 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS55164687A (en) | 1979-06-11 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS5566585A (en) | 1978-11-14 | 1980-05-20 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS55162791A (en) | 1979-06-05 | 1980-12-18 | Takeda Chem Ind Ltd | Antibiotic c-15003pnd and its preparation |
| JPS55164685A (en) | 1979-06-08 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS55164686A (en) | 1979-06-11 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| US4309428A (en) | 1979-07-30 | 1982-01-05 | Takeda Chemical Industries, Ltd. | Maytansinoids |
| JPS5622790A (en) * | 1979-07-31 | 1981-03-03 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS5645483A (en) | 1979-09-19 | 1981-04-25 | Takeda Chem Ind Ltd | C-15003phm and its preparation |
| JP3054741B2 (ja) * | 1989-09-29 | 2000-06-19 | 武田薬品工業株式会社 | Ｔａｎ―１３１３およびそのアシル誘導体 |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| EP2266607A3 (en) * | 1999-10-01 | 2011-04-20 | Immunogen, Inc. | Immunoconjugates for treating cancer |
| US6441163B1 (en) | 2001-05-31 | 2002-08-27 | Immunogen, Inc. | Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| TWI298067B (en) * | 2002-01-31 | 2008-06-21 | Daiso Co Ltd | New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| EP1651162B1 (en) | 2003-05-20 | 2015-10-21 | ImmunoGen, Inc. | Improved cytotoxic agents comprising new maytansinoids |
| JP2007503439A (ja) | 2003-08-22 | 2007-02-22 | アクティブバイオティクス インコーポレイティッド | リファマイシンアナログおよびそれらの使用法 |
| TR201808537T4 (tr) | 2004-09-23 | 2018-07-23 | Genentech Inc | Sistein değiştirilmiş antikorlar ve konjugatlar. |
| DK1819359T3 (en) * | 2004-12-09 | 2015-04-20 | Janssen Biotech Inc | ANTI-integrin immunoconjugates, processes for their preparation and their use |
| US7301019B2 (en) | 2005-01-21 | 2007-11-27 | Immunogen, Inc. | Method for the preparation of maytansinoid esters |
| WO2007011721A1 (en) * | 2005-07-15 | 2007-01-25 | Kalypsys, Inc. | Inhibitors of mitotic kinesin |
| EP1913002B9 (en) * | 2005-08-09 | 2012-04-25 | Millennium Pharmaceuticals, Inc. | Method of acylating maytansinol with chiral amino acids |
| EP1960406A2 (en) * | 2006-11-06 | 2008-08-27 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| JP2008288289A (ja) | 2007-05-16 | 2008-11-27 | Oki Electric Ind Co Ltd | 電界効果トランジスタとその製造方法 |
| WO2010141566A1 (en) | 2009-06-03 | 2010-12-09 | Immunogen, Inc. | Conjugation methods |
| EP2480557A2 (en) * | 2009-09-25 | 2012-08-01 | Cadila Healthcare Limited | Process for the preparation of rapamycin derivatives |
| CA2816426A1 (en) * | 2010-11-17 | 2012-06-07 | Genentech, Inc. | Alaninyl maytansinol antibody conjugates |
| MY169250A (en) | 2012-09-26 | 2019-03-19 | Immunogen Inc | Improved methods for the acylation of maytansinol |
-
2013
- 2013-09-26 MY MYPI2015000663A patent/MY169250A/en unknown
- 2013-09-26 LT LTEP18213678.8T patent/LT3486248T/lt unknown
- 2013-09-26 PL PL13774881T patent/PL2900676T3/pl unknown
- 2013-09-26 RU RU2015111635A patent/RU2648992C2/ru active
- 2013-09-26 RS RS20190314A patent/RS58493B1/sr unknown
- 2013-09-26 AU AU2013323572A patent/AU2013323572B2/en active Active
- 2013-09-26 HU HUE18213678A patent/HUE055443T2/hu unknown
- 2013-09-26 PT PT182136788T patent/PT3486248T/pt unknown
- 2013-09-26 PL PL18213678T patent/PL3486248T3/pl unknown
- 2013-09-26 RS RS20210825A patent/RS62075B1/sr unknown
- 2013-09-26 MX MX2015003745A patent/MX366701B/es active IP Right Grant
- 2013-09-26 PT PT13774881T patent/PT2900676T/pt unknown
- 2013-09-26 EP EP21166484.2A patent/EP3904358A1/en active Pending
- 2013-09-26 LT LTEP13774881.0T patent/LT2900676T/lt unknown
- 2013-09-26 ES ES18213678T patent/ES2880754T3/es active Active
- 2013-09-26 SM SM20190170T patent/SMT201900170T1/it unknown
- 2013-09-26 MX MX2019008652A patent/MX390615B/es unknown
- 2013-09-26 SM SM20210390T patent/SMT202100390T1/it unknown
- 2013-09-26 CA CA3133906A patent/CA3133906C/en active Active
- 2013-09-26 EP EP13774881.0A patent/EP2900676B1/en active Active
- 2013-09-26 HU HUE13774881A patent/HUE043285T2/hu unknown
- 2013-09-26 DK DK13774881.0T patent/DK2900676T3/en active
- 2013-09-26 EP EP18213678.8A patent/EP3486248B1/en active Active
- 2013-09-26 CN CN201380049853.8A patent/CN104768955B/zh active Active
- 2013-09-26 RU RU2018109295A patent/RU2765072C2/ru active
- 2013-09-26 US US14/037,657 patent/US9012629B2/en active Active
- 2013-09-26 TR TR2019/03625T patent/TR201903625T4/tr unknown
- 2013-09-26 SI SI201331899T patent/SI3486248T1/sl unknown
- 2013-09-26 ES ES13774881T patent/ES2716561T3/es active Active
- 2013-09-26 CN CN201810251853.0A patent/CN108586487B/zh active Active
- 2013-09-26 WO PCT/US2013/061839 patent/WO2014052537A1/en not_active Ceased
- 2013-09-26 HR HRP20190473TT patent/HRP20190473T1/hr unknown
- 2013-09-26 SG SG11201501918UA patent/SG11201501918UA/en unknown
- 2013-09-26 SI SI201331374T patent/SI2900676T1/sl unknown
- 2013-09-26 NZ NZ73957313A patent/NZ739573A/en unknown
- 2013-09-26 BR BR112015006505-8A patent/BR112015006505B1/pt active IP Right Grant
- 2013-09-26 JP JP2015534641A patent/JP6517693B2/ja active Active
- 2013-09-26 NZ NZ706019A patent/NZ706019A/en unknown
- 2013-09-26 BR BR122021022582-6A patent/BR122021022582B1/pt active IP Right Grant
- 2013-09-26 CA CA2884873A patent/CA2884873C/en active Active
- 2013-09-26 DK DK18213678.8T patent/DK3486248T3/da active
-
2015
- 2015-03-17 US US14/660,050 patent/US9469655B2/en active Active
- 2015-03-19 ZA ZA2015/01898A patent/ZA201501898B/en unknown
- 2015-03-23 IL IL237899A patent/IL237899A/en active IP Right Grant
-
2016
- 2016-09-19 US US15/269,163 patent/US9796731B2/en active Active
-
2017
- 2017-08-14 IL IL253988A patent/IL253988B/en active IP Right Grant
- 2017-09-19 US US15/708,346 patent/US10100062B2/en active Active
-
2018
- 2018-02-27 AU AU2018201392A patent/AU2018201392B2/en active Active
- 2018-02-27 JP JP2018032684A patent/JP2018109044A/ja not_active Ceased
- 2018-09-12 US US16/129,268 patent/US10461449B2/en active Active
-
2019
- 2019-03-13 CY CY20191100302T patent/CY1121415T1/el unknown
- 2019-09-18 US US16/574,718 patent/US10944190B2/en active Active
-
2020
- 2020-04-06 JP JP2020068137A patent/JP6735000B1/ja active Active
- 2020-06-10 AU AU2020203823A patent/AU2020203823B2/en active Active
- 2020-07-10 JP JP2020118929A patent/JP2020180150A/ja active Pending
-
2021
- 2021-06-29 HR HRP20211030TT patent/HRP20211030T1/hr unknown
- 2021-07-02 CY CY20211100594T patent/CY1124337T1/el unknown
-
2022
- 2022-02-28 JP JP2022029253A patent/JP2022068367A/ja active Pending
- 2022-03-07 AU AU2022201557A patent/AU2022201557A1/en not_active Abandoned
-
2023
- 2023-09-05 US US18/242,321 patent/US20240145953A1/en not_active Abandoned
- 2023-10-23 JP JP2023181529A patent/JP2024010055A/ja active Pending
-
2024
- 2024-01-19 US US18/417,406 patent/US20240313444A1/en not_active Abandoned
- 2024-05-31 US US18/679,863 patent/US20250007192A1/en active Pending
-
2025
- 2025-03-31 JP JP2025058629A patent/JP2025098242A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019008652A (es) | Metodos mejorados para la acilacion del maitansinol. | |
| PE20142359A1 (es) | Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| MX377552B (es) | Proceso para preparar un compuesto antiviral de formula i. | |
| CR20150370A (es) | Compuestos antivirales | |
| MX2015017870A (es) | Procedimiento para producir 4-propargilado amino-benzoxazinonas. | |
| MX350211B (es) | Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico. | |
| PH12018501094A1 (en) | Process for the preparation of an apoptosis-inducing agent | |
| EA201500234A1 (ru) | Способ получения бензоксазинонов | |
| MX2014014138A (es) | Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico. | |
| CL2011000296A1 (es) | Proceso de preparación del ester metílico del ácido 4-oxo-octahidro-indol-1-carboxílico y compuestos intermediarios utilizados. | |
| BR112014011314A2 (pt) | espessante, processo apara preparar um espessante, formulação ácida, usos de uma formulação ácida, de uma formulação alcalina, e de um espessante, e, formulação alcalina | |
| AR088377A1 (es) | Proceso para la preparacion de 6-cloro-2,3,4,9-tetrahidro-1h-carbazol-1-carboxamida y compuestos intermedios de esta | |
| IN2013MU01431A (OSRAM) | ||
| AR099070A1 (es) | Ácido (s)- 3-metil-abscísico y ésteres del mismo | |
| PE20150154A1 (es) | N-[4-(quinolin-4-iloxi)ciclohexil(metil)](hetero)arilcarboxamidas como antagonistas del receptor de androgenos, su produccion y usos como productos medicinales | |
| ES2670477R1 (es) | Procedimiento para la preparacion de la 17beta-hidroxi-des-a-androst-9,10-en-5-ona | |
| UY34277A (es) | Metodo para la eliminación del naftaleno | |
| IN2014DN10658A (OSRAM) | ||
| LT2012082A (lt) | Nauji fotochrominiai junginiai, jų gamybos būdas ir tarpiniai junginiai jiems gauti | |
| BR112017019391A2 (pt) | mistura para a produção de um corpo verde, processo para a produção de um corpo verde, e, corpo verde | |
| MX2018004735A (es) | Proceso y composiciones para lograr balance energetico de los mamiferos. | |
| IN2013MU02699A (OSRAM) | ||
| MX2017006512A (es) | Poliaminometilbenciloxalamidas y composiciones y metodos relacionados a estas. | |
| MX361673B (es) | Procedimiento para la preparación de intermediarios de ácido borónico. | |
| MX2017003498A (es) | Sal de ester metilico de fenilglicina. |